Ramy Tharwat

MBBCH, MRCPUK, Consultant in Stroke and Geriatric medicine , Husband , Dad and sometimes writer. tweets are my personal views.

[International Journal of Stroke @IntJStroke]

#FlashbackFriday !
📊Exploratory analyses of TRACE‑III

💉Tenecteplase (4.5–24h) may benefit late-window stroke patients without thrombectomy

👉❗️Effect depends on infarct growth rate

Read more here👇
https://t.co/KcktWObSGM

[Neil Stone @DrNeilStone]

This is what a REAL scientific breakthough looks like

Not nonsense about ivermectin and cancer

[Neurophilia @bobvarkey]

Posterior cerebral artery segments

[Omar Danoun, MD @omar_danoun]

New study suggests Levetiracetam (Keppra) increases clotting risk. But context matters, this is not a universal effect of the drug itself. The signal is a drug interaction, nearly double thromboembolic risk specifically when combined with DOACs like apixaban or rivaroxaban. Notably, this interaction has not been seen with warfarin. Levetiracetam alone does not raise clotting risk.

Clinical takeaway, for patients on a DOAC with a history of atrial fibrillation or DVT, consider switching from levetiracetam to an alternative such as lamotrigine that lacks this interaction, or discuss whether warfarin might be a suitable option instead.

[European Stroke Org @ESOstroke]

EVT improves functional outcome and reduces early neurological deterioration in patients with ischemic stroke due to anterior circulation LVO presenting within 0–24h with mild symptoms (NIHSS <6) and a favourable perfusion profile (core <50 mL; mismatch >50 mL).

#ESOC2026

[European Stroke Org @ESOstroke]

ESOC TV Highlights of the Day with @MicheleRomoli & @IsabelFragata.

Discussing IA thrombolysis following MT and Asundexian for secondary stroke prevention with @CheesemakerMD, Yang Xiang, Mukul Sharma & @Ash_Shoamanesh.

🔗 https://t.co/F6fesYVnjI
#ESOC2026 #VoiceOfStroke

[Ramy Tharwat @drramytharwat]

Attending the ESOC 2026 in Maastricht has been an absolutely incredible experience. What an amazing opportunity to meet and learn from so many dedicated stroke experts from around the world! #ESOC2026 #VoiceOfStroke #Networking

[European Stroke Org @ESOstroke]

🧊 The CHILL-ART trial shows that intra-arterial selective hypothermia during thrombectomy improves 90-day functional independence (54.7% vs 39.8%) without increasing safety risks.

There was no increase in haemorrhage or mortality.

@ESOstroke #ESOC2026 #StrokeTreatment

[Ramy Tharwat @drramytharwat]

Finding the right dose of early mobilisation after stroke 🧠

The AVERT-DOSE trial (1,000 pts, 50 hospitals, 7 countries) explores how timing & intensity of early rehab impact recovery after mild–moderate ischaemic stroke.

@ESOstroke #ESOC2026 #VoiceOfStroke #Stroke #ESOC2026

[European Stroke Org @ESOstroke]

TECNO trial: Intra-arterial Tenecteplase after incomplete thrombectomy is safe but doesn’t significantly improve reperfusion or outcomes vs standard care. More research needed to refine patient selection and treatment strategies in stroke care.

#ESOC2026 #VoiceOfStroke #Stroke

[European Stroke Org @ESOstroke]

Direct EVT was non-inferior to combined IVT + EVT in acute basilar artery occlusion in the Chinese BEST-BAO trial.

@ESOstroke #ESOC2026 #VoiceOfStroke #Stroke

[Ramy Tharwat @drramytharwat]

Attending the European Stroke Organization 12th Conference 2026 in Maastricht NL, more than 4000 healthcare professionals specialized in stroke medicine from around the world. #ESOC2026

[Katie Pardy @katielpardy]

👏👏👏👏

[Ramy Tharwat @drramytharwat]

@NaguibSawiris مش هيضرب ده هجاص، بيهددهم بس. لو ناوي كان ضرب من غير ما يقول.

[AshuJadhav @AshuPJadhav]

A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion | New England Journal of Medicine https://t.co/UCD9jsq62A

[JAMA Neurology @JAMANeuro]

Among patients <70 years with acute #BasilarArteryOcclusion, endovascular thrombectomy doubled the rate of ambulatory and self-care capable outcomes at 3 years vs medical treatment.

https://t.co/CycXRfNGAY

[الشرق بلومبرغ – مصر @AsharqbEGY]

40 عاما في مصر: رحلة ألمانية صنعت الفارق في الزراعة الحيوية

التفاصيل في برنامج "ويك اند القاهرة"

🔴 تابعوا اقتصاد الشرق للمزيد

[Stroke AHA/ASA @StrokeAHA_ASA]

🧵Check out the December 2025 Stroke Highlights by @NicoleBSur ⬇️

https://t.co/1RvfGdPie4

@MeyrePascal @cardiotfl @NicolasRodondi @BonatiLeo @LimaNeuro @NguyenThanhMD @JimSiegler

[Ramy Tharwat @drramytharwat]

@ABSamy18 كل سنه و قدسك طيب. سنه سعيده و مليانه خير يارب.

[Ramy Tharwat @drramytharwat]

@BishopAngaelos @CopticCentreUK @CopticCathedral @CopticDiocese @ServingLondon @StPaulMinistry @TheSanctuaryCDL It was a real blessing to have you with us Saydna. Happy New Year.